South Korea
Lunit Integrates AI Biomarker into Roche's navify® Platform, Boosting Precision in Cancer Biomarker Testing
Lunit's AI-powered biomarker, Lunit SCOPE PD-L1 TPS, integrates into Roche's navify® Digital Pathology platform to enhance precision medicine an...
September 10, 2024 | News
Neurophet Expands Global Reach with AI Brain Imaging Partnership and Research Recognition
Neurophet accelerates global expansion for research and partnership in AI-driven brain image analysis Neurophet, an artificial intelligence (AI) solution ...
September 10, 2024 | News
Seegene Launches Advanced Novaplex™ Assay to Combat High-Mortality Mpox Clade I
Introduces Novaplex™ MPXV/OPXV plus Assay (RUO) that is designed to detect Clade I, which has higher transmission and mortality rates than Cla...
September 10, 2024 | News
GC Biopharma and Hanmi Pharmaceutical Receive FDA Clearance for Phase 1/2 Trial of First Once-Monthly Subcutaneous Treatment for Fabry Disease
Co-development of innovative new drug for the treatment of Fabry disease as "the world's first once-monthly subcutaneous treatment" Improves efficacy co...
September 04, 2024 | News
Hyundai Bioscience Advances Xafty® as Sole Oral COVID-19 Treatment for High-Risk Patients Ineligible for Paxlovid®
"Xafty® can be the only oral COVID-19 treatment that can be prescribed to high-risk group patients who cannot take Paxlovid®" "While maintaining...
August 29, 2024 | News
Zuellig Pharma Secures Exclusive Distribution Agreement with Regeneron to Launch Libtayo® in South Korea and Taiwan
Zuellig Pharma, a leading healthcare solutions company in Asia, has announced an exclusive distribution agreement with Regeneron Ireland DAC, a wholly owne...
August 28, 2024 | News
Yunovia Gains MFDS Clearance for Phase 1 MAD Study of Oral GLP-1 Agonist for Diabetes and Obesity
Yunovia, a drug R&D subsidiary of Ildong Pharmaceutical Group, announced on the 26th that the Ministry of Food and Drug Safety (MFDS) of Korea has clea...
August 28, 2024 | News
South Korea's Seegene Develops Advanced Multiplex PCR Assays for Mpox and Other Viruses
Develops NovaplexTM MPXV/OPXV Assay and NovaplexTM HSV-1&2/VZV/MPXV Assay - Designed to detect four viruses at once using multip...
August 27, 2024 | News
CanariaBio Completes Enrollment for Phase 2 Study of Oregovomab with Chemotherapy in Advanced Ovarian Cancer
CanariaBio Inc, a leading late-stage biotechnology company, announces the successful completion of enrollment of 88 patients in a randomized Phase 2 study ...
August 26, 2024 | News
GE HealthCare and Roche Diagnostics Partner to Transform Precision Cancer Care in Asia Pacific
GE HealthCare and Roche Diagnostics have entered into a Memorandum of Understanding (MOU) that will leverage the strengths and resources of both comp...
August 22, 2024 | News
Samsung Biologics Joins PSCI to Enhance Responsible Supply Chain Management
Samsung Biologics to embed PSCI principles into business practices for responsible value chain management Supplier Partnership reaffirms company's commi...
August 07, 2024 | News
Bridge Biotherapeutics Completes Patient Enrollment for Phase 2 Study of BBT-877 in IPF Treatment
Bridge Biotherapeutics (KQ288330), a clinical-stage biotech company based in South Korea developing novel drugs for fibrosis and cancer, an...
July 30, 2024 | News
Daewoong Pharmaceutical's Bersiporocin Shows Positive Safety Data in Phase 2 Trial for IPF
Daewoong Pharmaceutical (Co-CEOs Chang-Jae Lee and Seongsoo Park) announced a significant milestone in the development of 'Bersiporocin (DWN...
July 30, 2024 | News
GCCL Launches R&D Division to Bolster Biosimilar and Clinical Trial Analysis Services
Newly established R&D division this year is expected to provide full-scale in-house R&D in addition to clinical sample analysis Including blockb...
July 17, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
